CEO Spotlight: Pat LePore, Par Pharmaceutical Companies

  • 12 years ago
04/24/2012 Pat LePore, Chairman and CEO of Par Pharmaceutical Companies discusses the latest developments for the company in the generic drug market. Par Pharmaceutical Companies celebrated the 25th anniversary of its listing on the NYSE.

Recommended